Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL737443

COc1ccc(C2(O)CCN(c3ccc(OCCCN4CCCCC4)cc3)CC2)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 6/20 0.60
MAPT P10636 3/20 0.60
POLB P06746 1/20 0.60
ALDH1A1 P00352 3/20 0.59
KMT2A Q03164 2/20 0.59
MEN1 O00255 1/20 0.59
LMNA P02545 1/20 0.59
KCNH2 Q12809 1/20 0.54
HTR1A P08908 1/20 0.49
DRD2 P14416 1/20 0.49
DRD1 P21728 1/20 0.49
DRD5 P21918 1/20 0.49
SLC6A2 P23975 1/20 0.49
HTR2A P28223 1/20 0.49
SLC6A4 P31645 1/20 0.49
HTR7 P34969 1/20 0.49
HRH1 P35367 1/20 0.49
DRD3 P35462 1/20 0.49
HTR2B P41595 1/20 0.49
KDM4E B2RXH2 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL738381 0.91 HRH3 (0.61) HRH3ALDH1A1KMT2AMEN1LMNA
Trifluoroacetic Acid SCHEMBL735794 0.90 ALDH1A1 (0.56) HRH3MAPTPOLBALDH1A1KMT2A
SCHEMBL737444 0.85 MAPT (0.55) HRH3MAPTPOLBALDH1A1KMT2A
Trifluoroacetic Acid SCHEMBL736519 0.84 HRH3 (0.55) HRH3MAPTPOLBALDH1A1KCNH2
SCHEMBL738421 0.84 HRH3 (0.70) HRH3MAPTALDH1A1KMT2AMEN1
Trifluoroacetic Acid SCHEMBL736504 0.84 HRH3 (0.51) HRH3ALDH1A1KCNH2HRH1KDM4E
Trifluoroacetic Acid SCHEMBL735635 0.83 HRH3 (0.57) HRH3MAPTPOLBALDH1A1KCNH2
Trifluoroacetic Acid SCHEMBL738424 0.80 HRH3 (0.52) HRH3ALDH1A1KCNH2HRH1KDM4E
Trifluoroacetic Acid SCHEMBL737476 0.80 HRH3 (0.55) HRH3MAPTPOLBALDH1A1KMT2A
Trifluoroacetic Acid SCHEMBL737095 0.80 HRH3 (0.55) HRH3MAPTPOLBALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138206-B2 Piperidine derivative MSD. K.K. (JP) 2012-03-20 US claimed
US-20090137576-A1 Novel Piperidine Derivative MSD K.K. (JP) 2009-05-28 US claimed
EP-1892241-A1 NOVEL PIPERIDINE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 2008-02-27 EP claimed
US-8138206-B2 Piperidine derivative MSD. K.K. (JP) 2012-03-20 US disclosed
US-20090137576-A1 Novel Piperidine Derivative MSD K.K. (JP) 2009-05-28 US disclosed
EP-1892241-A1 NOVEL PIPERIDINE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 2008-02-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137576-A1 Novel Piperidine Derivative HRH4, HRH3, HRH1 HRH3 2/4885MAPT 4377/4885POLB 3782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.